标题
Advances in Oligonucleotide Aptamers for NSCLC Targeting
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 17, Pages 6075
出版商
MDPI AG
发表日期
2020-08-24
DOI
10.3390/ijms21176075
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications
- (2020) Baozhang Guan et al. International Journal of Nanomedicine
- Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
- (2020) Zhaoying Fu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Aptamers in Non-Small Cell Lung Cancer Treatment
- (2020) Irena Wieleba et al. MOLECULES
- Targeted delivery of Rab26 siRNA with precisely tailored DNA prism for lung cancer therapy
- (2019) Qian Liu et al. CHEMBIOCHEM
- Development of DNA Aptamers to Native EpCAM for Isolation of Lung Circulating Tumor Cells from Human Blood
- (2019) Galina Zamay et al. Cancers
- Codelivery of Genistein and miRNA-29b to A549 Cells Using Aptamer-Hybrid Nanoparticle Bioconjugates
- (2019) Koita Sacko et al. Nanomaterials
- PD-L1 Expression with Epithelial Mesenchymal Transition of Circulating Tumor Cells Is Associated with Poor Survival in Curatively Resected Non-Small Cell Lung Cancer
- (2019) Yariswamy Manjunath et al. Cancers
- Selective eradication of human non-small cell lung cancer cells using aptamer-decorated nanoparticles harboring a cytotoxic drug cargo
- (2019) Shira Engelberg et al. Cell Death & Disease
- Axl-Targeted Delivery of the Oncosuppressor miR-137 in Non-small-Cell Lung Cancer
- (2019) Silvia Nuzzo et al. Molecular Therapy-Nucleic Acids
- Dual‑targeting nanomicelles with CD133 and CD44 aptamers for enhanced delivery of gefitinib to two populations of lung cancer‑initiating cells
- (2019) Xiaolong Huang et al. Experimental and Therapeutic Medicine
- Characterization of A Bifunctional Synthetic RNA Aptamer and A Truncated Form for Ability to Inhibit Growth of Non-Small Cell Lung Cancer
- (2019) Hanlu Wang et al. Scientific Reports
- Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer
- (2018) Tingting Lv et al. Acta Biomaterialia
- Evaluation of MUC1-Aptamer Functionalized Hybrid Nanoparticles for Targeted Delivery of miRNA-29b to Nonsmall Cell Lung Cancer
- (2018) Maryna Perepelyuk et al. MOLECULAR PHARMACEUTICS
- Ultrasensitive and high specific detection of non-small-cell lung cancer cells in human serum and clinical pleural effusion by aptamer-based fluorescence spectroscopy
- (2018) Yuhang Wu et al. TALANTA
- TEMPORARY REMOVAL: MAFG is a potential therapeutic target to restore chemosensitivity in cisplatin-resistant cancer cells by increasing reactive oxygen species
- (2018) Olga Vera-Puente et al. Translational Research
- Cancer cell-selective, clathrin-mediated endocytosis of aptamerdecorated nanoparticles
- (2018) Shira Engelberg et al. Oncotarget
- In Vivo SELEX of an Inhibitory NSCLC-Specific RNA Aptamer from PEGylated RNA Library
- (2018) Hanlu Wang et al. Molecular Therapy-Nucleic Acids
- Current Advances in Aptamers for Cancer Diagnosis and Therapy
- (2018) Shin-ichiro Hori et al. Cancers
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aptamer-miR-34c conjugate affects cell proliferation of non-small cell lung cancer cells
- (2018) Valentina Russo et al. Molecular Therapy-Nucleic Acids
- Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
- (2018) Ugo Testa et al. Cancers
- In vivo SELEX of bone targeting aptamer in prostate cancer bone metastasis model
- (2018) Lingxiao Chen et al. International Journal of Nanomedicine
- A Microwell-Assisted Multiaptamer Immunomagnetic Platform for Capture and Genetic Analysis of Circulating Tumor Cells
- (2018) Zaizai Dong et al. Advanced Healthcare Materials
- Aptamer-targeted delivery of Bcl-xL shRNA using alkyl modified PAMAM dendrimers into lung cancer cells
- (2017) Sara Ayatollahi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
- (2017) Zhenjian Zhuo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An aptamer for recognizing the transmembrane protein PDL-1 (programmed death-ligand 1), and its application to fluorometric single cell detection of human ovarian carcinoma cells
- (2017) Rezvan Yazdian-Robati et al. MICROCHIMICA ACTA
- Current approaches for avoiding the limitations of circulating tumor cells detection methods—implications for diagnosis and treatment of patients with solid tumors
- (2017) Artur Kowalik et al. Translational Research
- A Combined PD-1/C5a Blockade Synergistically Protects against Lung Cancer Growth and Metastasis
- (2017) Daniel Ajona et al. Cancer Discovery
- DNA Aptamers for the Characterization of Histological Structure of Lung Adenocarcinoma
- (2017) Galina S. Zamay et al. Molecular Therapy-Nucleic Acids
- Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins
- (2016) Sunday Shoyele et al. International Journal of Nanomedicine
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
- (2016) Thomas J. Povsic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
- (2016) Nancy J. Ganson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies
- (2016) Kyun Heo et al. JOURNAL OF CONTROLLED RELEASE
- AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol–Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non–Small Cell Lung Cancer In Vitro
- (2016) Mona Alibolandi et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Scientific Advances in Lung Cancer 2015
- (2016) Anne S. Tsao et al. Journal of Thoracic Oncology
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Enhanced and Differential Capture of Circulating Tumor Cells from Lung Cancer Patients by Microfluidic Assays Using Aptamer Cocktail
- (2016) Libo Zhao et al. Small
- Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL
- (2016) Margherita Iaboni et al. Molecular Therapy-Nucleic Acids
- A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects
- (2016) Wei-Yun Lai et al. Molecular Therapy-Nucleic Acids
- A recognition-before-labeling strategy for sensitive detection of lung cancer cells with a quantum dot–aptamer complex
- (2015) Chunlei Wu et al. ANALYST
- Ultrasensitive cytosensing based on an aptamer modified nanobiosensor with a bioconjugate: Detection of human non-small-cell lung cancer cells
- (2015) Tanveer A. Mir et al. BIOSENSORS & BIOELECTRONICS
- Cellular delivery of shRNA using aptamer-conjugated PLL-alkyl-PEI nanoparticles
- (2015) Saeedeh Askarian et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Epithelial cell adhesion molecule aptamer conjugated PEG–PLGA nanopolymersomes for targeted delivery of doxorubicin to human breast adenocarcinoma cell line in vitro
- (2015) Mona Alibolandi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- In vitro and in vivo evaluation of therapy targeting epithelial-cell adhesion-molecule aptamers for non-small cell lung cancer
- (2015) Mona Alibolandi et al. JOURNAL OF CONTROLLED RELEASE
- Mechanistic studies of anticancer aptamer AS1411 reveal a novel role for nucleolin in regulating Rac1 activation
- (2015) E. Merit Reyes-Reyes et al. Molecular Oncology
- Aptamers Selected to Postoperative Lung Adenocarcinoma Detect Circulating Tumor Cells in Human Blood
- (2015) Galina S Zamay et al. MOLECULAR THERAPY
- Capturing Cancer: Emerging Microfluidic Technologies for the Capture and Characterization of Circulating Tumor Cells
- (2015) Weiyi Qian et al. Small
- Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
- (2015) Aaron Prodeus et al. Molecular Therapy-Nucleic Acids
- Aptamer-Dendrimer Bioconjugates for Targeted Delivery of miR-34a Expressing Plasmid and Antitumor Effects in Non-Small Cell Lung Cancer Cells
- (2015) Hongmei Wang et al. PLoS One
- Methuosis
- (2014) William A. Maltese et al. AMERICAN JOURNAL OF PATHOLOGY
- Synergistic inhibition of lung cancer cell invasion, tumor growth and angiogenesis using aptamer-siRNA chimeras
- (2014) Wei-Yun Lai et al. BIOMATERIALS
- Multifunctional Aptamer-miRNA Conjugates for Targeted Cancer Therapy
- (2014) Carla L Esposito et al. MOLECULAR THERAPY
- DNA-Aptamer Targeting Vimentin for Tumor Therapy In Vivo
- (2014) Tatyana N. Zamay et al. Nucleic Acid Therapeutics
- Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
- (2014) Hongguang Sun et al. Molecular Therapy-Nucleic Acids
- DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro
- (2013) Yan Tan et al. ACTA PHARMACOLOGICA SINICA
- Specific Capture and Release of Circulating Tumor Cells Using Aptamer-Modified Nanosubstrates
- (2013) Qinglin Shen et al. ADVANCED MATERIALS
- MiRNA-29: A microRNA Family with Tumor-Suppressing and Immune-Modulating Properties
- (2013) M.J. Schmitt et al. CURRENT MOLECULAR MEDICINE
- Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines
- (2013) XIUPING YAN et al. ONCOLOGY REPORTS
- In Vitro Selection of Modified RNA Aptamers Against CD44 Cancer Stem Cell Marker
- (2013) Nidaa Ababneh et al. Nucleic Acid Therapeutics
- In vivo SELEX for Identification of Brain-penetrating Aptamers
- (2013) Congsheng Cheng et al. Molecular Therapy-Nucleic Acids
- RNA aptamers targeting cancer stem cell marker CD133
- (2012) Sarah Shigdar et al. CANCER LETTERS
- Biologic Challenges in the Detection of Circulating Tumor Cells
- (2012) S. A. Joosse et al. CANCER RESEARCH
- Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC)
- (2012) Corey J. Langer et al. CANCER TREATMENT REVIEWS
- Targeting Axl With an High-affinity Inhibitory Aptamer
- (2012) Laura Cerchia et al. MOLECULAR THERAPY
- Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro
- (2012) Yan Hu et al. PLoS One
- Current Progress of RNA Aptamer-Based Therapeutics
- (2012) Jiehua Zhou et al. Frontiers in Genetics
- RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule
- (2011) Sarah Shigdar et al. CANCER SCIENCE
- Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer
- (2011) Tomoaki Kurosaki et al. GENE
- Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer
- (2011) Matthew G. Krebs et al. JOURNAL OF CLINICAL ONCOLOGY
- A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
- (2011) Carla Lucia Esposito et al. PLoS One
- Development of a Lung Cancer Therapeutic Based on the Tumor Suppressor MicroRNA-34
- (2010) J. F. Wiggins et al. CANCER RESEARCH
- Induction of Nonapoptotic Cell Death by Activated Ras Requires Inverse Regulation of Rac1 and Arf6
- (2010) Haymanti Bhanot et al. MOLECULAR CANCER RESEARCH
- Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells
- (2009) Zilong Zhao et al. ANALYST
- Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer
- (2009) Paula J. Bates et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma
- (2009) Krepela INTERNATIONAL JOURNAL OF ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started